GSK’s RSV Vaccine Prospects In Youngest Pediatric Patients Looks Unlikely Per US FDA Label

 
• By Sarah Karlin-Smith
baby getting treated for respiratory disease
GSK will need a next generation RSV vaccine for infants and toddlers. • Source: Shutterstock

More from Vaccines

More from Pink Sheet